Austrian Biomarker Expert BIOCRATES Life Sciences GmbH and Canadian Chenomx Inc. Sign Co-Marketing Agreement

Published: Mar 10, 2010

INNSBRUCK, Austria--(BUSINESS WIRE)--Austrian biomarker developer BIOCRATES Life Sciences AG ( announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc ( Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.

Back to news